Browse > Article
http://dx.doi.org/10.12750/JET.2013.28.3.281

Establishment and Characterization of Bone Marrow Mesenchymal Stromal/Stem Cells (MSCs) Derived from ${\alpha}$-1,3-Galactosyltransferase Knock Out(GalT KO) Pig  

Ock, Sun-A (Animal Biotechnology Division, National Institute of Animal Science, Rural Development Administration)
Oh, Keon Bong (Animal Biotechnology Division, National Institute of Animal Science, Rural Development Administration)
Hwang, Seongsoo (Animal Biotechnology Division, National Institute of Animal Science, Rural Development Administration)
Im, Seoki (Animal Biotechnology Division, National Institute of Animal Science, Rural Development Administration)
Kim, Youngim (Animal Biotechnology Division, National Institute of Animal Science, Rural Development Administration)
Park, Jin-Ki (Animal Biotechnology Division, National Institute of Animal Science, Rural Development Administration)
Publication Information
Journal of Embryo Transfer / v.28, no.3, 2013 , pp. 281-287 More about this Journal
Abstract
A major barrier to progress in pig to primate organ transplantation or cell therapy is the presence of terminal ${\alpha}$-1,3-galactosyl epitopes on the surface of pig cells. Therefore, the purpose of this experiment was to establish and cha- racterize mesenchymal stromal/stem cells (MSCs) derived from ${\alpha}$-1,3-galactosyltransferase (GalT) knock out (GalT KO) pig to confirm their potential for cell therapy. Bone marrow (BM)-MSCs from GalT KO pig of 1 month old were isolated by Ficoll-Paque PLUS gradient and cultured with A-DMEM + 10% FBS on plastic dishes in 5% $CO_2$ incubator at 38.5. GalT KO BM-MSCs were analyzed for the expression of CD markers ($CD45^-$, $29^+$, $90^+$ and $105^+$) and in vitro differentiation ability (adiopogenesis and osteogenesis). Further, cell proliferation capacity and cell aging of GalT KO BM-MSCs were compared to Wild BM-MSCs by BrdU incorporation assay (Roche, Germany) using ELISA at intervals of two days for 7 days. Finally, the cell size was also evaluated in GalT KO and Wild BM-MSCs. Statistical analysis was performed by T-test (P<0.05). GalT KO BM-MSCs showed fibroblast-like cell morphology on plastic culture dish at passage 1 and exhibited $CD45^-$, $29^+$, $90^+$ and $105^+$ expression profile. Follow in ginduction in StemPro adipogenesis and osteogenesis media for 3 weeks, GalT KO BM-MSCs were differentiated into adipocytes, as demonstrated by Oilred Ostaining of lipid vacuoles and osteocytes, as confirmed by Alizarinred Sstaining of mineral dispositions, respectively. BrdU incorporation assay showed a significant decrease in cell proliferation capacity of GalT KO BM-MSCs compared to Wild BM-MSCs from 3 day, when they were seeded at $1{\times}10^3$ cells/well in 96-well plate. Passage 3 GalT KO and Wild BM-MSCs at 80% confluence in culture dish were allowed to form single cells to calculate cell size. The results showed that GalT KO BM-MSCs($15.0{\pm}0.4{\mu}m$) had a little larger cell size than Wild BM-MSCs ($13.5{\pm}0.3{\mu}m$). From the above findings, it is summarized that GalT KO BM-MSCs possessed similar biological properties with Wild BM-MSCs, but exhibited a weak cell proliferation ability and resistance to cell aging. Therefore, GalT KO BM-MSCs might form a good source for cell therapy after due consideration to low proliferation potency in vitro.
Keywords
${\alpha}$-1,3-galactosyltransferase knock out pig; mesenchymal stromal/stem cells; bone marrow; BrdU incorporation assay;
Citations & Related Records
Times Cited By KSCI : 1  (Citation Analysis)
연도 인용수 순위
1 Galili U. 2001. The alpha-Gal epitope(Galalpha1-3 Galbeta1-4-GlcNAc-R) in xenotransplantation. Biochimie. 83: 557-563.   DOI
2 Carrington JL. 2005. Aging bone and cartilage: cross-cutting issues. Biochem. Biophys. Res. Commun. 328: 700-708. Review.   DOI
3 Dai Y, Vaught TD, Boone J, Chen SH, Phelps CJ, Ball S, Monahan JA, Jobst PM, McCreath KJ, Lam born AE, Cowell-Lucero JL, Wells KD, Colman A, Polejaeva IA and Ayares DL 2002. Targeted disruption of the alpha 1,3-galactosyltransferase gene in cloned pigs. Nat. Biotechnol. 20: 251-255.   DOI
4 Ezzelarab M, Ezzelarab C, Wilhite T, Kumar G, Hara H, Ayares D and Cooper DK. 2011. Genetically-modified pig mesenchymal stromal cells: xenoantigenicity and effect on human T-cell xenoresponses. Xenotransplantation 18: 183-195.   DOI
5 Faast R, Harrison SJ, Beebe LF, McIlfatrick SM, Ashman RJ and Nottle MB. 2006. Use of adult mesenchymal stem cells isolated from bone marrow and blood for somatic cell nuclear transfer in pigs. Cloning Stem Cells 8: 166-173.   DOI
6 Im GS, Hwang SS, Oh KB, Kim DH, Woo JS, Shim HS, Yun IJ and Park JK. 2012. Production of $\alpha$1,3-galactosyltransferase( GalT) double knock-out(-/-) transgenic pigs for xenotransplantation. J. Emb. Trans. 27: 9-14.
7 Good AH, Cooper DK, Malcolm AJ, Ippolito RM, Koren E, Neethling FA, Ye Y, Zuhdi N and Lamontagne LR. 1992. Identification of carbohydrate structures that bind human antiporcine antibodies: implications for discordant xenografting in humans. Transplant. Proc. 24: 559-562.
8 Kumar G, Hara H, Long C, Shaikh H, Ayares D, Cooper DK and Ezzelarab M. 2012. Adipose-derived mesenchymal stromal cells from genetically modified pigs: immunogenicity and immune modulatory properties. Cytotherapy. 14: 494-504.   DOI
9 Ock SA, Jeon BG and Rho GJ. 2010. Comparative characterization of porcine mesenchymal stem cells derived from bone marrow extract and skin tissues. Tissue Eng. Part C Methods. 16: 1481-1491.   DOI
10 Kuwaki K, Tseng YL, Dor FJ, Shimizu A, Houser SL, Sanderson TM, Lancos CJ, Prabharasuth DD, Cheng J, Moran K, Hisashi Y, Mueller N, Yamada K, SL, Sanderson TM, Lancos CJ, Prabharasuth DD, Cheng J, Moran K, Hisashi Y, Mueller N, Yamada K, Greenstein JL, Hawley RJ, Patience C, Awwad M, Fishman JA, Robson SC, Schuurman HJ, Sachs DH and Cooper DK 2005. Heart transplantation in baboons using alpha 1,3-galactosyltransferase gene-knockout pigs as donors: initial experience. Nat. Med. 11: 29-31.   DOI
11 Schubert T, Poilvache H, Galli C, Gianello P and Dufrane D. 2013. Galactosyl-knock-out engineered pig as a xenogenic donor source of adipose MSCs for bone regeneration. Biomaterials. 34: 3279-3289.   DOI
12 Lermen DE, Gorjup, PW, Dyce H, von Briesen and Müler P. 2010. Neuro-muscular differentiation of adult porcine skin derived stem cell-like cells. PLoS One 29: e8968.
13 Nauta AJ and Fibbe WE. 2007. Immunomodulatory properties of mesenchymal stromal cells. Blood 110: 3499e 506.
14 Phelps CJ, Koike C, Vaught TD, Boone J, Wells KD, Chen SH, Ball S, Specht SM, Polejaeva IA, Monahan JA, Jobst PM, Sharma SB, Lamborn AE, Garst AS, Moore M, Demetris AJ, Rudert WA, Bottino R, Bertera S, Trucco M, Starzl TE, Dai Y and Ayares DL. 2003 Production of alpha 1,3-galactosyltransferase-deficient pigs. Science 299: 411-414.   DOI
15 Thompson P, Badell IR, Lowe M, Cano J, Song M, Leopardi F, Avila J, Ruhil R, Strobert E, Korbutt G, Rayat G, Rajotte R, Iwakoshi N, Larsen CP and Kirk AD. 2011. Islet xenotransplantation using gal-deficient neonatal donors improves engraftment and function. Am. J. Transplant. 11: 2593-2602.   DOI
16 Ahn KS, Kim YJ, Kim M, Lee BH, Heo SY, Kang MJ, Kang YK, Lee JW, Lee KK, Kim JH, Nho WG, Hwang SS, Woo JS, Park JK, Park SB and Shim H. 2011. Resurrection of an alpha-1,3-galactosyltransferase gene-targeted miniature pig by recloning using postmortem ear skin fibroblasts. Theriogenology 75: 933-999.   DOI
17 Vacanti V, Kong E, Suzuki G, Sato K, Canty JM and Lee T. 2005. Phenotypic changes of adult porcine mesenchymal stem cells induced by prolonged passaging in culture. J. Cell Physiol. 205: 194-201.   DOI
18 Zhou S, Greenberger JS, Epperly MW, Goff JP, Adler C, Leboff MS and Glowacki J. 2008. Age-related intrinsic changes in human bone-marrow-derived mesenchymal stem cells and their differentiation to osteoblasts. Aging Cell. 7: 335-343.   DOI
19 Abrahante JE, Martins K, Papas KK, Hering BJ, Schuurman HJ and Murtaugh MP. 2011. Microbiological safety of porcine islets: comparison with source pig. Xenotransplantation 18: 88e93.